Skip to main content

Guidelines

Having diabetes puts you at risk for problems with your kidneys. Learn about the steps you can take, as recommended in the latest ADA Standards of Care, to maintain the...
Obesity affects about one in five children in the United States and can lead to many health issues down the road, including type 2 diabetes. For the first time, the AAP...
The FDA has just announced that Rybelsus has now been approved as an initial treatment option for type 2 diabetes. In addition to the glucose-lowering effects, Rybelsus...
The National Kidney Foundation and the American Society of Nephrology created a new formula to measure kidney function. The “raceless eGFR” will begin to address...
In December, the American Diabetes Association (ADA) released its 2023 Standards of Care, which offer the ADA’s annual update on how healthcare providers should...
diaTribe and the Time in Range Coalition, in a global effort to raise the awareness and adoption of Time in Range and the use of continuous glucose monitors (CGM),...
Diet and exercise are often insufficient for people with obesity, leading many to pursue alternatives. The American Gastroenterological Association published guidelines...
Learn what some of the latest research says about the heart health benefits of diabetes drugs like SGLT-2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs.
The US Preventive Services Task Force (USPSTF) has updated its recommendations, encouraging prediabetes and type 2 diabetes screening for people with excess weight or...
Why do Asians and Asian Americans face an increased risk for diabetes and prediabetes? Joanne Saunders shares her father’s diabetes story to help shed light on this...
COVID-19 has revealed new and exciting ways we can confront the pandemic of diabetes. A new peer-reviewed paper sponsored by diaTribe outlines some of the lessons...
The American Diabetes Association recommends SGLT-2 inhibitors or GLP-1 agonists for people with heart and kidney problems, the use of Time in Range in diabetes...
Rice is a main food staple in many cultures, but it can cause glucose spikes for people with diabetes. From rice alternatives to smaller portions, here are some ways to...
Free software upgrade for t:slim X2 users, first G5-integrated pump on the market, CGM can be used for insulin dosing and remote monitoring
By Jimmy McDermott and Maeve Serino FreeStyle LibreLink app allows FreeStyle Libre users in the US to obtain a real-time glucose reading directly on their iPhone. Plus,...
A recent consensus report from leading experts details a new definition for what it means to have type 2 diabetes in remission and why it is important to use the proper...
The FDA’s decision on Bydureon was a shocker. We break down this decision and discuss why we view it as such a disappointment.
Medical technology manufacturer Valeritas announced earlier this month that it received FDA clearance to market its V-Go Disposable Insulin Delivery Device, which...
In early November, Kombiglyze, a pill combining DPP-4 inhibitor Onglyza and metformin, was approved by the FDA for type 2 diabetes. Onglyza was approved in July 2010...
In a major setback for MannKind Corporation ’s inhalable insulin therapy, Afrezza, the FDA is requiring the company to conduct two additional clinical trials of the...

Pages